Skip to content

A clinical trial to study the outcomes of intermittent stoppage of blood flow into the liver during donor hepatectomy for adult living donor liver transplantation using robotic approach

Outcomes of Intermittent Inflow Occlusion [IIO] by Pringle maneuver during robotic donor hepatectomy in adult living donor liver transplantation with right hemiliver grafts: A prospective, randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041567
Enrollment
68
Registered
2022-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intermittent Inflow Occlusion [IIO] technique by Pringle Maneuver during robotic donor hepatectomy using right hemiliver grafts: Each IIO procedure consisted of clamping of the hepatodu

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All prospective male and female liver donors between 18 - 60 years of age admitted for live donor liver transplantation with right hemiliver grafts using robotic donor hepatectomy

Exclusion criteria

Exclusion criteria: (1) Prospective donors who denied consent (2) Prospective donors of recipients with fulminant hepatic failure before liver transplantation (3) Prospective donors for ABO-incompatible liver transplant (4) Prospective donors of recipients who has undergone organ transplantation previously (5) Prospective donors of recipients who are scheduled to undergo multi organ transplantation

Design outcomes

Primary

MeasureTime frame
To compare the blood loss during Robotic Donor Hepatectomy with and without Intermittent Inflow Occlusion [IIO] by Pringle maneuver in adult living donor liver transplantation using right hemiliver graftsTimepoint: At the end of donor surgery [Robotic Donor Hepatectomy using right hemiliver grafts]

Secondary

MeasureTime frame
Blood transfusion requirements in donorTimepoint: During both intraoperative and postoperative period - upto the day of discharge from hospital;Early graft dysfunction incidenceTimepoint: Within 2 weeks from the date of liver transplantation;Hospital stay in donorTimepoint: Number of days - will be noted at the time of discharge;ICU stay in donorTimepoint: Number of days - will be noted at the time of shift from ICU to ward / room;Peak ALT level in donor within 7 days after surgeryTimepoint: Within 7 days after surgery;Peak ALT level in recipient within 7 days after surgeryTimepoint: Within 7 days after surgery;Peak Bilirubin level in donor within 7 days after surgeryTimepoint: Within 7 days after surgery;Peak INR level in donor within 7 days after surgeryTimepoint: Within 7 days after surgery;Peri-operative morbidity and mortality in recipient [within 30 days from date of transplantation]Timepoint: Within 30 days from the date of liver transplantation;Skin incision to graft out time in donor surgeryTimepoint: Data will be collected during the surgery;Time taken from beginning of parenchymal transection to hepatic vein looping in donor surgeryTimepoint: Data will be collected during the surgery;Total duration of donor surgeryTimepoint: Data will be collected at the end of the surgery;Warm ischemia and Cold ischemia time of graftTimepoint: Data will be collected at the end of the surgery

Countries

India

Contacts

Public ContactDr Rahul D Kunju

Amrita Institute of Medical Sciences Cochin, Kerala

sudhi@aims.amrita.edu9388623851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026